Study 43 of 44NAD+ (Nicotinamide Adenine Dinucleotide) literatureCell metabolismTop journal2026
A context-dependent framework for targeting NAD metabolism in cancer.
Not reported in abstract.
Where it sits
this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus19
Preclinical · this one
19
Observational
1
Open-label
1
Randomised
4
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus
DGenetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities.Nature metabolism · 2026—BPart 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injectionsbiorxiv-preprint · 2026 · 9.97% average daily increase in NAD+ for 100 mg IM.HumanBPart 2 of a 2-part open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 90 days of at-home subcutaneous injectionsbiorxiv-preprint · 2026 · GlycoATP decreased at Day 30, p<0.05.HumanDAn NAD(+)-responsive adipose signal coordinates inter-organ defense against muscle atrophy.Cell metabolism · 2026—BNicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.JAMA · 2026HumanCAdipose ILC2s depend on acetyl-CoA carboxylase 1 to maintain metabolic health.Cell metabolism · 2026 · Not reported in abstract.Animal